Sato T, Azuma Y, Ozone C, Okazaki M, et al. Possible Advantage of Glucagon-Like Peptide 1 Receptor Agonists for Kidney Transplant Recipients With Type 2 Diabetes. J Clin Endocrinol Metab 2023 Mar 28:dgad177. doi: 10.1210.
PMID: 36974363